Journal of Inborn Errors of Metabolism and Screening (Sep 2016)

Expert Opinions on Managing Fertility and Pregnancy in Patients With Mucopolysaccharidosis

  • Fiona Stewart MB, BS,
  • Andrew Bentley MD,
  • Barbara K Burton MD,
  • Nathalie Guffon MD,
  • Susan L. Hale MN, ARNP,
  • Paul R. Harmatz MD,
  • Susanne G. Kircher MD,
  • Pavan K. Kochhar MD,
  • John J. Mitchell MD,
  • Ursula Plöckinger MD,
  • Jennifer Semotok MSc, PhD,
  • Sue Graham MSc,
  • Stephen Sande PhD,
  • Zlatko Sisic MD,
  • Tracey A. Johnston MD

DOI
https://doi.org/10.1177/2326409816669375
Journal volume & issue
Vol. 4

Abstract

Read online

The mucopolysaccharidosis (MPS) disorders are rare genetic diseases caused by deficiencies in lysosomal enzymes involved in the degradation of glycosaminoglycans, leading to pulmonary, cardiac and neurological dysfunctions, skeletal anomalies, impaired vision, and/or hearing and shortened life spans. Whereas in the past, few individuals with MPS reached adulthood, better diagnosis, multidisciplinary care, and new therapies have led to an increasing number of adult patients with MPS. Therefore, fertility and pregnancy questions in this patient population are becoming more important. Management of fertility issues and pregnancy in patients with MPS is challenging due to the lack of documented cases and a dearth in the literature on this topic. This review presents multidisciplinary expert opinions on managing fertility and pregnancy based on case studies and clinical experience presented at a meeting of MPS specialists held in Berlin, Germany, in April 2015. An overview of the existing literature on this subject is also included.